Question 1

Does Waverly Advisors own SYRE stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Waverly Advisors holds 25,512 shares of SYRE (Spyre Therapeutics), worth $2.3M.

Question 2

How many shares of SYRE does Waverly Advisors own?

Accepted Answer

As of its Q2 2026 13F, Waverly Advisors holds 25,512 shares of SYRE (Spyre Therapeutics).

Question 3

What is Waverly Advisors' SYRE position worth?

Accepted Answer

As of its Q2 2026 13F, Waverly Advisors' SYRE position is worth $2.3M.

Question 4

Is Waverly Advisors buying or selling SYRE?

Accepted Answer

In Q2 2026, Waverly Advisors reduced its SYRE position by 454 shares (-1.8%).

Question 5

When did Waverly Advisors first buy SYRE?

Accepted Answer

Waverly Advisors first reported SYRE in its Q1 2025 13F and has listed it in 6 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	25,512	-1.8%	$2.3M	0.0%	$88.78	0
2026-Q1	Increased	25,966	+0.1%	$1.3M	0.0%	$50.44	25
2025-Q4	Increased	25,954	0.0%	$850,253	0.0%	$32.76	25
2025-Q3	Increased	25,953	+33.4%	$434,972	0.0%	$16.76	31
2025-Q2	Increased	19,453	+0.1%	$291,211	0.0%	$14.97	23
2025-Q1	New	19,430	—	$313,503	0.0%	$16.14	32